A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
Clinical trial NCT01464190 · COMPLETED
Trial details
- NCT number
- NCT01464190
- Sponsor
- Vifor Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-10-01
- Enrollment
- 659
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.